» Articles » PMID: 38001499

Ectopic and Visceral Fat Deposition in Aging, Obesity, and Idiopathic Pulmonary Fibrosis: an Interconnected Role

Overview
Publisher Biomed Central
Date 2023 Nov 24
PMID 38001499
Authors
Affiliations
Soon will be listed here.
Abstract

Idiopathic pulmonary fibrosis (IPF) is considered an age-related disease. Age-related changes, along with other factors such as obesity, hormonal imbalances, and various metabolic disorders, lead to ectopic fat deposition (EFD). This accumulation of fat outside of its normal storage sites is associated with detrimental effects such as lipotoxicity, oxidative stress, inflammation, and insulin resistance. This narrative review provides an overview of the connection between ectopic and visceral fat deposition in aging, obesity, and IPF. It also elucidates the mechanism by which ectopic fat deposition in the airways and lungs, pericardium, skeletal muscles, and pancreas contributes to lung injury and fibrosis in patients with IPF, directly or indirectly. Moreover, the review discusses the impact of EFD on the severity of the disease, quality of life, presence of comorbidities, and overall prognosis in IPF patients. The review provides detailed information on recent research regarding representative lipid-lowering drugs, hypoglycemic drugs, and lipid-targeting drugs in animal experiments and clinical studies. This may offer new therapeutic directions for patients with IPF.

Citing Articles

Heart failure with preserved ejection fraction and metabolic dysfunction-associated steatotic liver disease: Twin challenges, one metabolic solution.

Lian L, Huang C, Chen Q, Zhou X World J Cardiol. 2025; 17(2):103845.

PMID: 40061276 PMC: 11886398. DOI: 10.4330/wjc.v17.i2.103845.


Body Fat and Visceral Fat Values in Spanish Healthcare Workers: Associated Variables.

Tarraga Marcos P, Lopez-Gonzalez A, Martinez-Almoyna Rifa E, Paublini Oliveira H, Martorell Sanchez C, Tarraga Lopez P Nutrients. 2025; 17(4).

PMID: 40004977 PMC: 11858298. DOI: 10.3390/nu17040649.


IA-Body Composition CT at T12 in Idiopathic Pulmonary Fibrosis: Diagnosing Sarcopenia and Correlating with Other Morphofunctional Assessment Techniques.

Fernandez-Jimenez R, Sanmartin-Sanchez A, Cabrera-Cesar E, Espildora-Hernandez F, Vegas-Aguilar I, Del Mar Amaya-Campos M Nutrients. 2024; 16(17).

PMID: 39275202 PMC: 11396836. DOI: 10.3390/nu16172885.


Higher body mass index was associated with a lower mortality of idiopathic pulmonary fibrosis: a meta-analysis.

Pan D, Wang Q, Yan B, Su X J Health Popul Nutr. 2024; 43(1):124.

PMID: 39152474 PMC: 11330017. DOI: 10.1186/s41043-024-00620-5.


Correlation between type 2 diabetes mellitus remission and intrapancreatic fat deposition.

Liu J, Luo Y, Zhu Y, Wu Z, Hou Y, Xu Y World J Clin Cases. 2024; 12(21):4536-4542.

PMID: 39070807 PMC: 11235486. DOI: 10.12998/wjcc.v12.i21.4536.

References
1.
Seenak P, Kumphune S, Prasitsak T, Nernpermpisooth N, Malakul W . Atorvastatin and ezetimibe protect against hypercholesterolemia-induced lung oxidative stress, inflammation, and fibrosis in rats. Front Med (Lausanne). 2023; 9:1039707. PMC: 10111198. DOI: 10.3389/fmed.2022.1039707. View

2.
Li C, Yu K, Shyh-Chang N, Jiang Z, Liu T, Ma S . Pathogenesis of sarcopenia and the relationship with fat mass: descriptive review. J Cachexia Sarcopenia Muscle. 2022; 13(2):781-794. PMC: 8977978. DOI: 10.1002/jcsm.12901. View

3.
David A, Jeste D, Folstein M, Folstein S . Voluntary movement dysfunction in Huntington's disease and tardive dyskinesia. Acta Neurol Scand. 1987; 75(2):130-9. DOI: 10.1111/j.1600-0404.1987.tb07907.x. View

4.
Tan W, Liao W, Zhou S, Mei D, Wong W . Targeting the renin-angiotensin system as novel therapeutic strategy for pulmonary diseases. Curr Opin Pharmacol. 2017; 40:9-17. DOI: 10.1016/j.coph.2017.12.002. View

5.
Okada S, Kozuka C, Masuzaki H, Yasue S, Ishii-Yonemoto T, Tanaka T . Adipose tissue-specific dysregulation of angiotensinogen by oxidative stress in obesity. Metabolism. 2010; 59(9):1241-51. PMC: 2891233. DOI: 10.1016/j.metabol.2009.11.016. View